Neuren Pharmaceuticals | NEU - Ebit

Stock Price
11.48
Daily Change
0.08 0.70%
Monthly
-12.23%
Yearly
-6.36%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD17.01M in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Clinuvel Pharmaceuticals AUD 32.21M 14.41M Jun/2024
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Genetic Signatures AUD -6.34M 1.23M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
Medical Developments International AUD -36K 12.96M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 154.09M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Paradigm Biopharmaceuticals AUD -10.31M 38.57M Jun/2025
PYC Therapeutics AUD -22.59M 3.25M Dec/2025
Starpharma Holdings AUD -873K 161K Dec/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025